生命科学资讯

Is It Time To Reconsider Agilent Technologies (A) After Recent Share Price Weakness - Yahoo Finance UK

First-movers respond to herding; BioMarin vets start new biotech; GSK buys RAPT Therapeutics; and more

BAM Wealth Management LLC Acquires Shares of 1,858 Thermo Fisher Scientific Inc. $TMO - MarketBeat

Baillie Gifford & Co. Lowers Stake in Illumina, Inc. $ILMN - MarketBeat

Thermo Fisher Scientific (NYSE:TMO) Upgraded by Wall Street Zen to Buy Rating - MarketBeat

Agilent launches high-throughput digital pathology slide scanner in Europe - Medical Economics

Novo's Wegovy pill off to a solid start after just two weeks on market

Anti-vaccine sentiment pushes Moderna away from new late-stage infectious disease trials

EU kicks off one-year pilot to expedite multinational trials

ACIP members depict diverging goals after schedule change

US completes withdrawal from WHO

Appointments and advancements for Jan. 23, 2026

Financings for Jan. 23, 2026

In the clinic for Jan. 23, 2026

Other news to note for Jan. 23, 2026

Sanofi to seek approval of touted eczema drug despite mixed results

Will Agilent’s (A) New AI-Enabled Slide Scanner Redefine Its Role in Digital Pathology Workflows? - simplywall.st

Will Agilent’s (A) New AI-Enabled Slide Scanner Redefine Its Role in Digital Pathology Workflows? - simplywall.st

F2G CEO outlines biotech's FDA resubmission plans, funding and expansion

Assessing 10x Genomics (TXG) Valuation After Recent Share Price Momentum - Yahoo Finance